Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive...

Area of Science:

• Immunology
• Virology
• Pediatrics

Background:

• SARS-CoV-2 infection severity differs between children and adults.
• Understanding early innate immune responses is crucial for managing COVID-19.

Purpose of the Study:

• To longitudinally analyze early innate immune responses in children and adults with mild SARS-CoV-2 infection.
• To compare the antiviral immune signatures and inflammatory control between pediatric and adult COVID-19 cases.

Main Methods:

• Longitudinal analysis of mild SARS-CoV-2 infections within household clusters.
• Assessment of viral load, symptoms, interferon gene responses, cytokine profiles (CXCL10, GM-CSF), blood cell counts, and B cell activation markers.
• Comparison of immune response resolution timelines and immune cell activation patterns between children and adults.

Main Results:

• Children presented with fewer symptoms than adults, despite similar initial viral loads.
• Children mounted a robust antiviral immune signature, including early interferon responses and increased cytokines.
• The antiviral response resolved faster in children (within one week), with transient monocyte and dendritic cell activation and earlier B cell gene expression, without impacting antibody quality.

Conclusions:

• Children's enhanced early control of inflammation, characterized by a rapid antiviral immune response, is critical for limiting SARS-CoV-2 disease severity.
• Pediatric immune responses to SARS-CoV-2 demonstrate efficient early infection control and faster resolution compared to adults.
• These findings highlight the importance of early innate immune dynamics in determining COVID-19 disease outcomes.